Integrity Alliance’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Integrity Alliance’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$959K	Sell	6,059 -2	-0%	-$270	0.03%	364
2026 Q1	$774K	Buy	6,061 +129	+2%	+$16.1K	0.03%	348
2025 Q4	$723K	Buy	+5,932	New	+$680K	0.03%	375
2025 Q2	–	Sell	-2,913	Closed	-$236K	–	674
2025 Q1	$236K	Buy	+2,913	New	+$260K	0.01%	542

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Integrity Alliance's XBI Position: Q2 2026 in Review

Integrity Alliance reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.03% in Q2 2026, selling an estimated $270 and leaving 6,059 shares worth $959K. The position accounts for 0.03% of the portfolio, ranked #364.

Integrity Alliance first reported a position in XBI in Q1 2025 and has held it in 4 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Integrity Alliance held 6,059 shares of State Street SPDR S&P Biotech ETF worth $959K as of Q2 2026.
Integrity Alliance sold 2 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $270.
State Street SPDR S&P Biotech ETF made up 0.03% of Integrity Alliance's portfolio in Q2 2026, its #364 holding.
Integrity Alliance first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and has held it in 4 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.